Menu Search
Equities

Prestige Consumer Healthcare Inc

PBV:FRA

Prestige Consumer Healthcare Inc

Actions
  • Price (EUR)66.50
  • Today's Change1.00 / 1.53%
  • Shares traded1.00
  • 1 Year change+23.15%
  • Beta--
Data delayed at least 15 minutes, as of Sep 19 2024 15:07 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Prestige Consumer Healthcare Inc had revenues remain flat at 1.13bn, though the company grew net income from a loss of 82.31m to a gain of 209.34m.
Gross margin55.32%
Net profit margin18.43%
Operating margin29.58%
Return on assets6.17%
Return on equity12.98%
Return on investment6.42%
More ▼

Cash flow in USDView more

In 2024, cash reserves at Prestige Consumer Healthcare Inc fell by 12.02m. However, the company earned 248.93m from its operations for a Cash Flow Margin of 22.12%. In addition the company used 20.11m on investing activities and also paid 241.02m in financing cash flows.
Cash flow per share4.71
Price/Cash flow per share15.42
Book value per share33.92
Tangible book value per share-23.52
More ▼

Balance sheet in USDView more

Prestige Consumer Healthcare Inc has a Debt to Total Capital ratio of 39.39%, a lower figure than the previous year's 89.01%.
Current ratio3.23
Quick ratio1.90
Total debt/total equity0.6498
Total debt/total capital0.3939
More ▼

Growth rates in USD

SmartText is unavailable
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		337.77
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.